HealthJanuary 22, 2026

Shadow AI: Providers are using unapproved tools to improve workflow

New survey data on shadow AI use in healthcare shows that providers of all practices and experiences use unsanctioned AI tools to improve workflows.

As healthcare AI tools proliferate, teams are using unauthorized solutions that introduce organizational risk to security, data, and patient safety. This “shadow AI” creates critical awareness gaps for leaders of all organizational sizes.

Healthcare users turn to shadow AI for faster workflows—and initial studies are showing AI tools are significantly reducing documentation time and improving the physician-patient experience. However, AI solutions used without enterprise oversight can introduce risks and challenges.

Three key takeaways on providers and shadow AI

To understand these usage gaps, Wolters Kluwer Health commissioned a December 2025 survey of over 500 healthcare workers, half administrators and half providers.1 Across all respondents, 17% admitted to using unauthorized AI tools in the workplace. Upon analyzing the data from providers, a few key highlights emerged.

1. Providers are using unauthorized AI for more efficient workflows

Of those who confirmed they have used unapproved AI tools, 45% said their primary reason was for a faster workflow. An additional 24% said their primary reason was for better functionality than the currently approved tools, supporting the need to include clinician input in enterprise tool selection.

2. Providers are more likely to experiment with unapproved AI tools

One key area where providers and administrators differed was in tool experimentation. Of those who had used unapproved tools, 26% of providers did so out of curiosity or experimentation, compared to 10% of administrators. If enterprise standards aren’t established, clinicians will try out new tools that can suit their workflows.

3. AI tools are used by providers across all lengths of practice

Many organizations are approaching unsanctioned AI tool usage as a challenge primarily with residents and younger clinicians. However, among providers who had less than 5 years of experience, only 14% had used unsanctioned AI tools, and 16% indicated that they had never used AI tools. Of those who had more than 5 years of experience and had used unapproved AI tools, 42% used them for faster workflows, 29% out of curiosity and experimentation, and 23% because they provided better functionality than approved solutions.

An enterprise-wide AI policy is key

For leaders, it’s crucial to clearly establish and communicate AI policies to the entire enterprise. It’s also important for providers to be included in AI tool selection to ensure evidence-based solutions are considered—without input, they may return to using their preferred tools in the shadows.

Explore more survey findings in our free whitepaper, “Shadow AI: A hidden risk for healthcare.”

Download The Whitepaper
Explore UpToDate Enterprise

1Online survey of hospital and health system providers and administrators conducted on behalf of Wolters Kluwer Health. N=518, comprised of 256 providers and 262 administrators. Conducted December 2025. Data on file.

As shadow AI continues to be more prevalent, clinicians should only use purpose-built GenAI systems that are trained on expert-validated evidence, transparent with source citations, and capable of tailored recommendations. GenAI will provide an increase in staff efficiency and care quality, but we must preserve safety and clinician-patient relationships by reframing workflows that elevate GenAI from a tool to a partner, keeping patients at the center of care.
Greg Samios, CEO, Wolters Kluwer Health
Back To Top